328 related articles for article (PubMed ID: 19444436)
1. Studies on the role of calcium phosphate in the process of calcium oxalate crystal formation.
Tiselius HG; Lindbäck B; Fornander AM; Nilsson MA
Urol Res; 2009 Aug; 37(4):181-92. PubMed ID: 19444436
[TBL] [Abstract][Full Text] [Related]
2. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
Robertson WG
Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
[TBL] [Abstract][Full Text] [Related]
3. The influence of hydroxyapatite seed on the crystallization induced by volume reduction of solutions with an ion composition corresponding to that in the distal tubule at different pH levels.
Højgaard I; Fornander AM; Nilsson MA; Tiselius HG
Scand J Urol Nephrol; 1998 Sep; 32(5):311-9. PubMed ID: 9825392
[TBL] [Abstract][Full Text] [Related]
4. Crystallization during volume reduction of solutions with a composition corresponding to that in the collecting duct: the influence of hydroxyapatite seed crystals and urinary macromolecules.
Højgaard I; Fornander AM; Nilsson MA; Tiselius HG
Urol Res; 1999 Dec; 27(6):417-25. PubMed ID: 10651129
[TBL] [Abstract][Full Text] [Related]
5. Crystallization during volume reduction of solutions with an ion-composition corresponding to that in the distal tubuli.
Højgaard I; Fornander AM; Nilsson MA; Tiselius HG
Scanning Microsc; 1996; 10(2):487-97; discussion 497-8. PubMed ID: 9813626
[TBL] [Abstract][Full Text] [Related]
6. A hypothesis of calcium stone formation: an interpretation of stone research during the past decades.
Tiselius HG
Urol Res; 2011 Aug; 39(4):231-43. PubMed ID: 21246193
[TBL] [Abstract][Full Text] [Related]
7. The effect of seed crystals of hydroxyapatite and brushite on the crystallization of calcium oxalate in undiluted human urine in vitro: implications for urinary stone pathogenesis.
Grover PK; Kim DS; Ryall RL
Mol Med; 2002 Apr; 8(4):200-9. PubMed ID: 12149569
[TBL] [Abstract][Full Text] [Related]
8. Intratubular crystallization of calcium oxalate in the presence of membrane vesicles: an in vitro study.
Fasano JM; Khan SR
Kidney Int; 2001 Jan; 59(1):169-78. PubMed ID: 11135069
[TBL] [Abstract][Full Text] [Related]
9. Crystallisation properties in stone forming and normal subjects' urine diluted using a standardised procedure to match the composition of urine in the distal part of the distal tubule and the middle part of the collecting duct.
Tiselius HG; Hallin A; Lindbäck B
Urol Res; 2001 Apr; 29(2):75-82. PubMed ID: 11396732
[TBL] [Abstract][Full Text] [Related]
10. Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis.
Schwille PO; Schmiedl A; Herrmann U; Fan J; Gottlieb D; Manoharan M; Wipplinger J
Urol Res; 1999 Apr; 27(2):117-26. PubMed ID: 10424393
[TBL] [Abstract][Full Text] [Related]
11. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
Schwille PO; Schmiedl A; Manoharan M
Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers.
Bek-Jensen H; Tiselius HG
Urol Res; 1997; 25(5):365-72. PubMed ID: 9373919
[TBL] [Abstract][Full Text] [Related]
13. Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.
Robertson WG
Urolithiasis; 2017 Feb; 45(1):43-56. PubMed ID: 27900407
[TBL] [Abstract][Full Text] [Related]
14. The effect of pH changes on the crystallization of calcium salts in solutions with an ion composition corresponding to that in the distal tubule.
Højgaard I; Fornander AM; Nilsson MA; Tiselius HG
Urol Res; 1999 Dec; 27(6):409-16. PubMed ID: 10651128
[TBL] [Abstract][Full Text] [Related]
15. The effect of pH on the risk of calcium oxalate crystallization in urine.
Berg C; Tiselius HG
Eur Urol; 1986; 12(1):59-61. PubMed ID: 3948899
[TBL] [Abstract][Full Text] [Related]
16. Relationship between supersaturation and crystal inhibition in hypercalciuric rats.
Asplin JR; Bushinsky DA; Singharetnam W; Riordon D; Parks JH; Coe FL
Kidney Int; 1997 Mar; 51(3):640-5. PubMed ID: 9067894
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
Schwille PO; Schmiedl A; Wipplinger J
Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
[TBL] [Abstract][Full Text] [Related]
18. Estimated levels of supersaturation with calcium phosphate and calcium oxalate in the distal tubule.
Tiselius HG
Urol Res; 1997; 25(2):153-9. PubMed ID: 9144885
[TBL] [Abstract][Full Text] [Related]
19. Calcium oxalate crystal deposition in kidneys of hypercalciuric mice with disrupted type IIa sodium-phosphate cotransporter.
Khan SR; Glenton PA
Am J Physiol Renal Physiol; 2008 May; 294(5):F1109-15. PubMed ID: 18337544
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology-based treatment of idiopathic calcium kidney stones.
Coe FL; Evan A; Worcester E
Clin J Am Soc Nephrol; 2011 Aug; 6(8):2083-92. PubMed ID: 21825103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
